Skip Navigation

Eligible for a Hair Relaxer lawsuit?

Lawyers To Nominate Hair Relaxer Cancer Cases for Early Bellwether Trials Next Week

Lawyers To Nominate Hair Relaxer Cancer Cases For Early Bellwether Trials Next Week

As lawyers continue to work on pretrial discovery in thousands of hair relaxer lawsuits brought by women nationwide, the U.S. District Judge presiding over the litigation has ordered each side to identify six representative cases next week, from which the Court will select three claims involving the development of uterine cancer, endometrial cancer or ovarian cancer that will be eligible for the first bellwether trials.

Lawsuits over the risk of cancer linked to hair relaxer side effects first emerged in late 2022, following the publication of a study by the National Institutes of Health, which found that women who regularly used hair relaxer products faced more than double the risk of developing uterine cancer compared to those who did not use the products. 

In the growing number of claims that have been filed since the release of the study, plaintiffs claim those risks stem from chemical ingredients commonly found in hair straighteners, including phthalates, parabens and formaldehyde-releasing agents, which have been linked to hormone disruption and tumor growth in reproductive tissues.

As of this month, more than 11,000 hair relaxer cancer lawsuits have been filed against cosmetics manufacturers such as Lโ€™Oreal, Revlon and others, with plaintiffs alleging the companies failed to warn consumers about potential cancer risks associated with chemical hair straighteners marketed under brands like Just for Me, Dark & Lovely and Optimum.

Given common questions of fact and law raised in complaints filed throughout the federal court system, all hair relaxer lawsuits have been consolidated before U.S. District Judge Mary Rowland in the Northern District of Illinois since 2023, for coordinated discovery and pretrial proceedings.

In May 2025, Judge Rowland ordered the parties to choose a group of 32 hair relaxer lawsuits to serve as potential bellwether cases, which may be ready to go before juries by the second half of 2027. While the outcome of these early test trials will not be binding on other claims, they will be closely watched to provide plaintiffs and defendants with a view into how juries will digest evidence and testimony that will likely be repeated throughout the litigation.

Over the past year, the parties have conducted depositions and case-specific discovery, seeking to narrow the claims down to just a few representative cases. Fact discovery for the initial 32 hair relaxer bellwether pool claims is expected to be completed by March 18. In addition, Judge Rowland has ordered the parties to turn in a list of 12 cases, six each, from that initial pool that they believe could serve as bellwether trials.

Once the lists are turned in, Judge Rowland has indicated she will select three claims by April 1 to serve as the actual bellwether trial cases. By April 6, plaintiffs will choose one of the cases to be prepared for trial. Defendants will choose another claim by April 10.

Afterward, the Court will select a second group of three potential bellwether cases by April 15, with plaintiffs choosing one of those cases by April 24, and defendants will select another by April 30.

The selections come after a status conference held last week, during which the parties discussed stipulations regarding marketing, advertising, label warnings and instructions, according to court minutes (PDF) issued that day. During the conference, Judge Rowland gave plaintiffs until March 26 to file motions for class action certification and expert disclosures.

To stay up to date on this litigation, sign up to receive hair relaxer lawsuit news delivered directly to your inbox.

Written By: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Cartiva implant lawsuits are moving forward in federal court as patients across the United States seek compensation for complications linked to the recalled big toe device.
An Abbott spinal cord stimulator lawsuit filed by three women says the product was defectively designed, inappropriately approved by the FDA, and left them with severe injuries, worsening pain and the need for removal surgery.
A Georgia couple’s lawsuit claims the makers of Dupixent failed to provide adequate warnings about the risk of mycosis fungoides, a type of T-cell lymphoma.